Back to Newsroom
Back to Newsroom

StemSation(TM) Signs Agreement with Award-Winning Global Marketing Agency Expects Significant Online Sales Impact by Q4

Thursday, 13 August 2020 08:55 AM

StemSation International, Inc.

BOCA RATON, FL / ACCESSWIRE / August 13, 2020 / StemSation International, Inc. (OTC PINK:STSN) - a pioneer in the emerging category of dietary supplements called Stem Cell Nutrition, announces that it has signed an agreement with First Class Alliance (FCA), an award-winning digital marketing and licensing agency that has worked with some of the most recognizable global brands in the United States.

FCA is an expert at enhancing brand awareness in the ever-changing world of digital marketing, helping companies to more effectively reach and connect with online consumers. Ray Carter, StemSation President & CEO commented, "We are very pleased to be collaborating with an impressive group like FCA to help us to stay on the forefront of digital technology and effectively share our unique and powerful story with the world".

StemSation creates and markets all-natural consumer health products that support the two most recently discovered biological systems of the human body - stem cells and endocannabinoids, releasing its first three novel products to support immune health and joint & muscle health. John Bejarano, FCA Founder & CEO commented, "FCA has a real passion for building unique brands that can make a positive impact in people's lives and StemSation certainly fits that criteria". They not only embrace change, they are innovators who create change, with impactful technology that is in timely demand given the world's current healthcare demands".

The global market for cannabidiol (CBD) is growing rapidly, estimated to reach $9.2 billion in 2020. The market has consistently grown over the last several years and is expecting to exceed more than $23.6 billion by 2025 at an impressive CAGR of 22.2% in the given forecast period, as reported by Grandview Research December, 2019 ( Hemp-derived CBD-infused personal care products are rising significantly in demand.

Bone and joint health have become a major public health concern across the globe. According to statistics, about 75 million people in the United States, Europe, and Japan have bone health concerns, and the population with bone and joint health issues is growing at alarming rates, as more baby boomers enter their 60's and early 70's globally. Joint health used to predominantly be associated with older people, but not anymore. Younger generations are concerned about their physical fitness, mobility, and joint and muscle health. .

StemSation is a company with a long-term ‘health mission', ambitious research goals, and innovative, holistic approaches to health & wellness, and healthy longevity. Our product line shows a new pathway to wellness.


StemSation International, Inc. (OTC "STSN") develops, manufactures and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body through using a direct selling model in which Independent Wellness Advocates ("IWAs") advertise and sell its products directly to consumers. StemSation is headquartered in Boca Raton, Florida and its website can be located at


This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.


Nicholas B. Panza, Vice President
StemSation International, Inc.
7777 Glades Road
Suite 203
Boca Raton, FL 33434
[email protected]
(561) 245-7454

SOURCE: StemSation International, Inc.

Company Update
Back to newsroom
Back to Newsroom

Contact Us Today

If you have questions or want to learn more about our products, our team’s here to help!

Share by: